Alteration of cancer pain-related signals by radiation: Proteomic analysis in an animal model with cancer bone invasion
- 1. Department of Radiation Oncology, Hallym University, Chuncheon (Korea, Republic of)
- 2. Department of Radiation Oncology, Brain Korea 21 Project for Medicine, Yonsei University, Seoul (Korea, Republic of)
- 3. Yonsei Medical Research Center, Brain Korea 21 Project for Medicine, Yonsei University, Seoul (Korea, Republic of)
Description
Purpose: Although radiotherapy is highly effective in relieving bone pain due to cancer invasion, its mechanism remains unclear. The aim of this study was to explore this mechanism in an animal model system. Methods and Materials: A hind paw model of cancer pain was developed by transplanting a murine hepatocarcinoma, HCa-1, into the periosteal membrane of the foot dorsum of C3H/HeJ mice. Bone invasion from HCa-1 was histopathologically confirmed from sequential tumor sampling. For three experimental groups, a control (N), tumor without radiation (T), and tumor with radiation (TR), the development and level of pain were objectively examined in mice with a growing tumor by assessing pain-associated behavior. The differential expression of pain-related signals in the spinal cord was analyzed by proteomic analysis using high-resolution two-dimensional gel electrophoresis (2-DE) and mass spectrometry, and those of proteins by Western blotting. The pain-mediating neurotransmitters in the spinal cord were also examined by immunohistochemical staining for calcitonin gene-related peptide (CGRP) and substance P. Results: In the histopathologic examinations, bone invasion from HCa-1 was seen from Day 7 and was evident at Day 14 after transplantation, and measurable pain-associated behaviors were developed from Day 7. After 25 Gy of radiation to the tumors, the objective level of pain in the TR group decreased, with higher thresholds to mechanical and thermal stimulation than in the T group. From the 2-DE of spinal cord, 107 spots were identified; 12 proteins were changed more than fivefold because of tumor formation but then reversed after radiation in the tumor-bearing mice. The proteins involved included secretagogin, syntenin, P2X purinoreceptor 6 (P2X6), and Ca2+/Calmodulin-dependent protein kinase 1 (CaM kinase 1), the functions of which have been known to be involved in the Ca2+-signaling cascade, ATP-mediated fast synaptic transmission, or control of vesicular trafficking. Validations using Western blotting were successful for the CaM kinase and P2X6. In immunohistochemical staining of the spinal cord, a significant decrease after irradiation was shown in the expression of CGRP, but not in substance P. Conclusions: We developed a novel model for bone pain due to cancer invasion, which was confirmed by histopathologic examination and measurable pain-associated behaviors. Radiotherapy decreased the objective level of pain. The underlying mechanism seems to be related to the Ca2+-signaling cascade or control of vesicular trafficking
Additional details
Identifiers
- DOI
- 10.1016/j.ijrobp.2004.12.070;
- PII
- S0360-3016(05)00032-5;
Publishing Information
- Journal Title
- International Journal of Radiation Oncology, Biology and Physics
- Journal Volume
- 61
- Journal Issue
- 5
- Journal Page Range
- p. 1523-1534
- ISSN
- 0360-3016
- CODEN
- IOBPD3
INIS
- Country of Publication
- United States
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 37012099
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- ATP; CALCITONIN; CALCIUM IONS; CALMODULIN; ELECTROPHORESIS; IRRADIATION; MASS SPECTROSCOPY; MICE; NEOPLASMS; PAIN; RADIOTHERAPY; SAMPLING; SPATIAL RESOLUTION; SPINAL CORD; STIMULATION
- Descriptors DEC
- ANIMALS; CENTRAL NERVOUS SYSTEM; CHARGED PARTICLES; DISEASES; HORMONES; IONS; MAMMALS; MEDICINE; NERVOUS SYSTEM; NUCLEAR MEDICINE; NUCLEOTIDES; ORGANIC COMPOUNDS; PEPTIDE HORMONES; PEPTIDES; POLYPEPTIDES; PROTEINS; RADIOLOGY; RESOLUTION; RODENTS; SPECTROSCOPY; SYMPTOMS; THERAPY; VERTEBRATES
Optional Information
- Copyright
- Copyright (c) 2005 Elsevier Science B.V., Amsterdam, Netherlands, All rights reserved.